WHO Guideline on Country Pharmaceutical Pricing Policies
- PMID: 25473702
- Bookshelf ID: NBK258631
WHO Guideline on Country Pharmaceutical Pricing Policies
Excerpt
Medicines account for 20–60% of health spending in low- and middle-income countries, compared with 18% in countries of the Organisation for Economic Co-operation and Development. Up to 90% of the population in developing countries purchase medicines through out-of-pocket payments, making medicines the largest family expenditure item after food. As a result, medicines, particularly those with higher costs, may be unaffordable for large sections of the global population and are a major burden on government budgets.
Copyright © World Health Organization 2013.
Sections
- Acknowledgements
- Overall coordination
- Funding and declarations of interest
- Executive summary
- 1. Introduction
- 2. Target audience
- 3. Scope of the guideline
- 4. How this guideline was developed
- 5. Recommendations
- 6. Guideline use and adaptation – key principles and general considerations
- 7. Research priorities and guideline update
- 8. References
- 9. Annexes
Publication types
LinkOut - more resources
Full Text Sources